NYSE:TARO - Taro Pharmaceutical Industries Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $81.00
  • Forecasted Upside: 6.62 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$75.97
▲ +0.06 (0.08%)
1 month | 3 months | 12 months
Get New Taro Pharmaceutical Industries Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TARO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TARO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$81.00
▲ +6.62% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Taro Pharmaceutical Industries in the last 3 months. The average price target is $81.00, with a high forecast of $81.00 and a low forecast of $81.00. The average price target represents a 6.62% upside from the last price of $75.97.
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Taro Pharmaceutical Industries. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/1/2021HC WainwrightBoost Price TargetBuy$80.00 ➝ $81.00Low
i
11/23/2020HC WainwrightLower Price TargetBuy$82.00 ➝ $80.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
7/27/2020HC WainwrightLower Price TargetBuy$96.00 ➝ $82.00Low
i
Rating by Ram Selvaraju at HC Wainwright
6/19/2020HC WainwrightReiterated RatingBuy$96.00Low
i
Rating by Ram Selvaraju at HC Wainwright
5/21/2020HC WainwrightReiterated RatingBuy$94.00 ➝ $96.00High
i
Rating by Ram Selvaraju at HC Wainwright
2/4/2020HC WainwrightLower Price TargetBuy$110.00 ➝ $94.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
11/5/2019HC WainwrightReiterated RatingBuy$105.00 ➝ $110.00High
i
Rating by Ram Selvaraju at HC Wainwright
8/12/2019HC WainwrightLower Price TargetBuy$115.00 ➝ $105.00Medium
i
12/10/2018HC WainwrightReiterated RatingBuy$115.00Low
i
Rating by Ram Selvaraju at HC Wainwright
10/1/2018HC WainwrightReiterated RatingBuy$120.00Low
i
Rating by Ram Selvaraju at HC Wainwright
8/10/2018HC WainwrightReiterated RatingBuy$120.00High
i
Rating by Ram Selvaraju at HC Wainwright
5/22/2018HC WainwrightSet Price TargetBuy$130.00Low
i
Rating by Ram Selvaraju at HC Wainwright
5/15/2018HC WainwrightSet Price TargetBuy$124.00Low
i
Rating by Ram Selvaraju at HC Wainwright
4/2/2018HC WainwrightSet Price TargetBuy$124.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
3/12/2018HC WainwrightInitiated CoverageBuy$124.00Medium
i
Rating by R. Selvaraju at HC Wainwright
5/23/2017Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
i
(Data available from 4/21/2016 forward)
Taro Pharmaceutical Industries logo
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Read More

Today's Range

Now: $75.97
$75.70
$76.54

50 Day Range

MA: $75.22
$70.70
$78.80

52 Week Range

Now: $75.97
$53.95
$80.00

Volume

18,386 shs

Average Volume

30,380 shs

Market Capitalization

$2.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Frequently Asked Questions

What sell-side analysts currently cover shares of Taro Pharmaceutical Industries?

The following Wall Street sell-side analysts have issued research reports on Taro Pharmaceutical Industries in the last year: HC Wainwright, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for TARO.

What is the current price target for Taro Pharmaceutical Industries?

1 Wall Street analysts have set twelve-month price targets for Taro Pharmaceutical Industries in the last year. Their average twelve-month price target is $81.00, suggesting a possible upside of 6.6%. HC Wainwright has the highest price target set, predicting TARO will reach $81.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $81.00 for Taro Pharmaceutical Industries in the next year.
View the latest price targets for TARO.

What is the current consensus analyst rating for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TARO will outperform the market and that investors should add to their positions of Taro Pharmaceutical Industries.
View the latest ratings for TARO.

What other companies compete with Taro Pharmaceutical Industries?

How do I contact Taro Pharmaceutical Industries' investor relations team?

Taro Pharmaceutical Industries' physical mailing address is 14 HAKITOR ST PO BOX 10347, HAIFA BAY L3, 10532. The company's listed phone number is 914-345-9000 and its investor relations email address is [email protected] The official website for Taro Pharmaceutical Industries is www.taro.com.